Research - Initial Experience of Intravesical Gemcitabine for Patients With High-Risk Superficial Transitional Cell Carcinoma Of the Bladder Following BCG Failure

Research - Initial Experience of Intravesical Gemcitabine for Patients With High-Risk Superficial Transitional Cell Carcinoma Of the Bladder Following BCG Failure


Identification: unj_ma14_05
Issue: March-April 2014
Volume: Volume 34 Number 2

Standard: $15.00

Author(s)

Speaker(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

References